Molecular Partners Q2 EPS $(0.89) Misses $(0.45) Estimate

Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.45) by 95.56 percent. This is a 31.34 percent decrease over losses of $(0.67) per share from the same period last year.